Page last updated: 2024-10-22

amobarbital and Sarcoma

amobarbital has been researched along with Sarcoma in 2 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
JUHASZ, J1
BALO, J1
KENDREY, G1
Mordarski, M1
Chylińska, B1
Urbański, T1

Other Studies

2 other studies available for amobarbital and Sarcoma

ArticleYear
[New experimental strain of tumor; amytal ascites sarcoma].
    Acta morphologica Academiae Scientiarum Hungaricae, 1955, Volume: 5, Issue:3-4

    Topics: Amobarbital; Animals; Ascites; Barbiturates; Neoplasms; Sarcoma; Sarcoma, Experimental

1955
Antitumor properties of 1,3-oxazine derivatives. I. Derivatives of 5-nitrotetrahydro-1,3-oxazines.
    Archivum immunologiae et therapiae experimentalis, 1970, Volume: 18, Issue:6

    Topics: Amobarbital; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Lymphoma; Mice; Neoplasms, Ex

1970